Immunovant Inc. – Investors and Politicians Who Own It
IMVT, 2 share classes and securities
Investors who own it
6 tracked investors, $1.1B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
David KroinDeep Track Capital, Q2 2026 | $359.9M | 5.24% |
Farallon Capital ManagementQ2 2026 | $223.7M | 1.03% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $209.4M | 1.05% |
Rod WongRTW Investments, Q2 2026 | $122.4M | 1.05% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $89.8M | 4.11% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $52.3M | 0.79% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Andreas Halvorsen | Reduced −39% | 1,407,290 |
| David Kroin | Added +38% | 6,000,000 |
| Joseph Edelman | Reduced −10% | 2,139,199 |
| Rod Wong | New | 530,614 |
| Daniel Schneeberger | Reduced −30% | 787,478 |
| Julian i Felix Baker | Added +39% | 1,707,881 |
| Daniel SchneebergerCall | Sold out | 0 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.